T Cell Therapy Market to Reach US$ 9,035.01 Million by 2030
T cell therapy is an advanced immunotherapy approach that harnesses a patient’s own immune cells to recognize and destroy cancer cells. By genetically modifying T cells to target specific tumor antigens, this therapy offers a personalized and highly targeted treatment strategy. Its transformative clinical outcomes in certain hematologic malignancies have positioned it as one of the most...
0 Reacties
0 aandelen
15 Views